These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 1548041)

  • 21. Identification of specific residues of human interleukin 2 that affect binding to the 70-kDa subunit (p70) of the interleukin 2 receptor.
    Collins L; Tsien WH; Seals C; Hakimi J; Weber D; Bailon P; Hoskings J; Greene WC; Toome V; Ju G
    Proc Natl Acad Sci U S A; 1988 Oct; 85(20):7709-13. PubMed ID: 3051003
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Preferential proliferation of T cell receptor V gamma 3-positive cells in IL-2-stimulated fetal thymocytes.
    Leclercq G; De Smedt M; Tison B; Plum J
    J Immunol; 1990 Dec; 145(12):3992-7. PubMed ID: 2147932
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inhibition of interleukin-2/p55 receptor subunit interaction by complementary peptides.
    Fassina G; Cassani G; Gnocchi P; Fornasiero MC; Isetta AM
    Arch Biochem Biophys; 1995 Apr; 318(1):37-45. PubMed ID: 7726570
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Interleukin 4 reverses T cell proliferative unresponsiveness and prevents the onset of diabetes in nonobese diabetic mice.
    Rapoport MJ; Jaramillo A; Zipris D; Lazarus AH; Serreze DV; Leiter EH; Cyopick P; Danska JS; Delovitch TL
    J Exp Med; 1993 Jul; 178(1):87-99. PubMed ID: 8315397
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Expression in Escherichia coli of fully active recombinant human IL 1 beta: comparison with native human IL 1 beta.
    Tocci MJ; Hutchinson NI; Cameron PM; Kirk KE; Norman DJ; Chin J; Rupp EA; Limjuco GA; Bonilla-Argudo VM; Schmidt JA
    J Immunol; 1987 Feb; 138(4):1109-14. PubMed ID: 2949012
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Reconstitution of the intermediate-affinity interleukin-2 receptor by cell fusion.
    Kuida K; Tanaka T; Kitamura F; Toyama-Sorimachi N; Miyasaka M
    Int Immunol; 1992 Oct; 4(10):1123-8. PubMed ID: 1489730
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Expression of functional interleukin-2 receptors in human light chain/Tac transgenic mice.
    Nishi M; Ishida Y; Honjo T
    Nature; 1988 Jan; 331(6153):267-9. PubMed ID: 2827038
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The IL-2 receptor beta-chain (p70). Ligand binding ability of the cDNA-encoding membrane and secreted forms.
    Tsudo M; Karasuyama H; Kitamura F; Tanaka T; Kubo S; Yamamura Y; Tamatani T; Hatakeyama M; Taniguchi T; Miyasaka M
    J Immunol; 1990 Jul; 145(2):599-606. PubMed ID: 2365996
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Induction and upregulation by interleukin 2 of high-affinity interleukin 2 receptors on thymocytes and T cells.
    Reem GH; Yeh NH; Urdal DL; Kilian PL; Farrar JJ
    Proc Natl Acad Sci U S A; 1985 Dec; 82(24):8663-6. PubMed ID: 3936041
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Limited proteolysis of recombinant human soluble interleukin-2 receptor. Identification of an interleukin-2 binding core.
    Miedel MC; Hulmes JD; Pan YC
    J Biol Chem; 1989 Dec; 264(35):21097-105. PubMed ID: 2687272
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A second human interleukin-2 binding protein that may be a component of high-affinity interleukin-2 receptors.
    Dukovich M; Wano Y; Le thi Bich Thuy ; Katz P; Cullen BR; Kehrl JH; Greene WC
    Nature; 1987 Jun 11-17; 327(6122):518-22. PubMed ID: 3108674
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A requirement for IL-2/IL-2 receptor signaling in intrathymic negative selection.
    Bassiri H; Carding SR
    J Immunol; 2001 May; 166(10):5945-54. PubMed ID: 11342609
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Anti-CD3 antibody-induced expression of both p55 and p75 chains of the high affinity interleukin-2 receptor on human T lymphocytes is inhibited by cyclosporin A.
    Foxwell BM; Simon J; Herrero JJ; Taylor D; Woerly G; Cantrell D; Ryffel B
    Immunology; 1990 Jan; 69(1):104-9. PubMed ID: 2312149
    [TBL] [Abstract][Full Text] [Related]  

  • 34. IL-2 receptors on circulating natural killer cells and T lymphocytes. Similarity in number and affinity but difference in transmission of the proliferation signal.
    Ben Aribia MH; Moiré N; Métivier D; Vaquero C; Lantz O; Olive D; Charpentier B; Senik A
    J Immunol; 1989 Jan; 142(2):490-9. PubMed ID: 2783438
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Impaired mitogen-induced expression of high-affinity interleukin 2 receptors on spleen cells from NOD/Shi/Kbe mice.
    Hatamori N; Yokono K; Nagata M; Shii K; Baba S
    Diabetes; 1990 Sep; 39(9):1070-8. PubMed ID: 2384189
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mutation of Asp20 of human interleukin-2 reveals a dual role of the p55 alpha chain of the interleukin-2 receptor.
    Flemming CL; Russell SJ; Collins MK
    Eur J Immunol; 1993 Apr; 23(4):917-21. PubMed ID: 8458377
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Novel interleukin-2 receptor subunit detected by cross-linking under high-affinity conditions.
    Sharon M; Klausner RD; Cullen BR; Chizzonite R; Leonard WJ
    Science; 1986 Nov; 234(4778):859-63. PubMed ID: 3095922
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Activation of the immune system of cancer patients by continuous i.v. recombinant IL-2 (rIL-2) therapy is dependent on dose and schedule of rIL-2.
    Gratama JW; Bruin RJ; Lamers CH; Oosterom R; Braakman E; Stoter G; Bolhuis RL
    Clin Exp Immunol; 1993 May; 92(2):185-93. PubMed ID: 8485906
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Trypanosoma cruzi reduces the number of high-affinity IL-2 receptors on activated human lymphocytes by suppressing the expression of the p55 and p70 receptor components.
    Kierszenbaum F; Cuna WR; Beltz LA; Sztein MB
    J Immunol; 1989 Jul; 143(1):275-9. PubMed ID: 2659667
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Receptors for interleukin 2 on human squamous cell carcinoma cell lines and tumor in situ.
    Weidmann E; Sacchi M; Plaisance S; Heo DS; Yasumura S; Lin WC; Johnson JT; Herberman RB; Azzarone B; Whiteside TL
    Cancer Res; 1992 Nov; 52(21):5963-70. PubMed ID: 1394222
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.